基本信息
views: 4
Career Trajectory
Bio
Dr. Peduzzi’s primary research interest involves the design, conduct, and analysis of multi-site randomized clinical trials with a particular focus on pragmatic clinical trials. Recent research has focused on issues related to the design and analysis complex clustered randomized trials with recurrent events in the presence of a semi-competing risk of death. Other research is focused on the design of patient preference clinical trials and hybrid Bayesian-frequentist trial designs.
Specialized Terms: Pragmatic Clinical trials; Patient Preference Clinical Trials; Biostatistics; Aging
Research Interests
Papers共 70 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CONTEMPORARY CLINICAL TRIALS (2024)
JAMA surgeryno. 12 (2023): e234856-e234856
Cost effectiveness and resource allocation : C/Eno. 1 (2023): 49-49
Statistical methods in medical researchno. 2 (2022): 305-333
Statistical methods in medical researchno. 7 (2022): 1224-1241
Journal of the American College of Surgeonsno. 5 (2022): S275-S276
David A. Ganz,Anita H. Yuan,Erich J. Greene,Nancy K. Latham,Katy Araujo,Albert L. Siu,Jay Magaziner,Jerry H. Gurwitz,Albert W. Wu,Neil B. Alexander,Robert B. Wallace,Susan L. Greenspan,Jeremy Rich,Elena Volpi,Stephen C. Waring,Patricia C. Dykes,Fred Ko,Neil M. Resnick,Siobhan K. McMahon,Shehzad Basaria,Rixin Wang,Charles Lu,Denise Esserman,James Dziura,Michael E. Miller,Thomas G. Travison,Peter Peduzzi,Shalender Bhasin,David B. Reuben,Thomas M. Gill
Load More
Author Statistics
#Papers: 70
#Citation: 5085
H-Index: 21
G-Index: 70
Sociability: 6
Diversity: 0
Activity: 1
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn